pharma deal

AstraZeneca to buy China’s Gracell Bio for up to $1.2 billion

[ad_1] London: AstraZeneca said on Tuesday it will buy Gracell Biotechnologies for up to $1.2 billion as the Anglo-Swedish pharma…